• HEDGEYE’S MARKET BRIEF
    Our FREE Investing Newsletter
    Get Exclusive Summer Sale Discounts

    By joining our email marketing list you agree to receive marketing emails from Hedgeye. You may unsubscribe at any time by clicking the unsubscribe link in one of the emails. Not available for current subscribers to that product. Use of Hedgeye and any other products available through hedgeye.com are subject to our Terms Of Service and Privacy Policy New users only.

Takeaway: Please join our policy team as they discuss the implications of mid-term elections on the Trump agenda in 2019 and beyond.

Please join Emily Evans, Health Policy Managing Director; Paul Glenchur, Senior Analyst, Telecommunications & Cable; and Daryl Jones, Director of Research on Thursday, Oct. 18th @ 2pm ET for a preview of the policy and political implications of the mid-term elections on President Trump's agenda in 2019 and beyond. Along with prognostications on who will control the House and the Senate come January, our analysts will also discuss:

  • Implications for anti-trust enforcement on select sectors like beverages, airlines, health care, and technology. Both President Trump and Democrats have highlighted excessive consolidation in certain industries as a policy concern. Democrats' takeover of the House may pave the way for changes to 30 years or more of anti-trust regulation.
  • Infrastructure spending and the possibility of a grand bargain between Republicans and Democrats. President Trump's goal of a massive infrastructure initiative has been stymied by deficit hawks who may get more influential after the 2018 elections. Will bi-partisanship win the day?
  • Trade policy - more of the same? With moderates retiring or going down in defeat, free-trade influences may be reduced thus further emboldening the president and making Wall Street nervous
  • Drug prices and the slow disintegration of PhaRMA's influence. Trump's efforts to "break" Washington has extended to most corners of the capital including the venerable and usually unbeatable pharmaceutical lobby. A win for Democrats could mean bi-partisan cooperation on legislative changes.

Access the webcast and presentation materials HERE. We will be distributing a replay of the webcast shortly after the call concludes for those of you who cannot join us live. 

Dial-in details:

  • Toll Free:
  • Toll:
  • UK: 0
  • Confirmation Number: 13683529

CALL TODAY | POLICY PREVIEW OF 2018 MIDTERM ELECTIONS - Midterm Preview   Venn

Kind regards,

-The Hedgeye Macro Team